Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients

Akio Osa, Takeshi Uenami, Shohei Koyama, +30

JCI Insight

Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells

Yuhei Kinehara, Izumi Nagatomo, Shohei Koyama, +32

JCI Insight

Egfr-tki ResistanceCancer BiologyTumor BiologyMtor ActivationCancer Cell Biology +15

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres

Taro Koba, Yoshito Takeda, Ryohei Narumi, +30

ERJ Open Research

Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis

Takeshi Tsuda, Masayuki Nishide, Yohei Maeda, +23

Journal of Allergy and Clinical Immunology

Tumor-derived semaphorin 4A improves PD-1–blocking antibody efficacy by enhancing CD8 ⁺ T cell cytotoxicity and proliferation

Yujiro Naito, Shohei Koyama, Kentaro Masuhiro, +40

Science Advances

Fatal cytomegalovirus pneumonia in a critically ill patient with <scp>COVID</scp>‐19

Saori Amiya, Haruhiko Hirata, Takayuki Shiroyama, +12

Respirology Case Reports

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients

Kota Iwahori, Takeshi Uenami, Yukihiro Yano, +15

Scientific Reports

IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor Immunity

Yasuhiko Suga, Izumi Nagatomo, Yuhei Kinehara, +22

The Journal of Immunology

Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles

Yu Futami, Yoshito Takeda, Taro Koba, +27

International Immunology

Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study

Kinnosuke Matsumoto, Takayuki Shiroyama, Motohiro Tamiya, +19

Cancer Immunology Immunotherapy